BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tomblyn M, Chen M, Kukreja M, Aljurf MD, Al Mohareb F, Bolwell BJ, Cahn JY, Carabasi MH, Gale RP, Gress RE, Gupta V, Hale GA, Ljungman P, Maziarz RT, Storek J, Wingard JR, Young JA, Horowitz MM, Ballen KK. No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantation. Transpl Infect Dis 2012;14:468-78. [PMID: 22548788 DOI: 10.1111/j.1399-3062.2012.00732.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu YC, Hsu CM, Hsiao SY, Hsiao HH. Hepatitis B Virus Infection in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation. J Pers Med 2021;11:1108. [PMID: 34834460 DOI: 10.3390/jpm11111108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Yu C, Sun Y, Xu L, Zhang X, Liu K, Jin J, Huang X, Wang Y. Hepatitis B Seropositive Status in Recipients or Donors Is Not Related to Worse Outcomes after Haploidentical Hematopoietic Stem Cell Transplantation. Transplant Cell Ther 2021;27:668.e1-9. [PMID: 34052506 DOI: 10.1016/j.jtct.2021.05.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Carreras E, Rovira M. Monitoring and management of hepatitis B, C, and HIV infection before and after transplantation. Blood and Marrow Transplantation Long Term Management 2021. [DOI: 10.1002/9781119612780.ch15] [Reference Citation Analysis]
4 Ljungman P. Anti‐infective prophylaxis, immunization and prevention of late infectious complications. Blood and Marrow Transplantation Long Term Management 2021. [DOI: 10.1002/9781119612780.ch13] [Reference Citation Analysis]
5 Slater SS, Hansen LK. Long-Term Follow-Up and Survivorship. Blood and Marrow Transplant Handbook 2021. [DOI: 10.1007/978-3-030-53626-8_51] [Reference Citation Analysis]
6 Kao RL, Holtan SG. Host and Graft Factors Impacting Infection Risk in Hematopoietic Cell Transplantation. Infect Dis Clin North Am 2019;33:311-29. [PMID: 30940461 DOI: 10.1016/j.idc.2019.02.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
7 Liu JH, Liao XW, Chen CH, Yao M, Li CC, Lin CT, Tsai CH, Chou WC, Hou HA, Huang SY, Wu SJ, Chen YC, Tien HF, Tang JL, Ko BS. Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study. Br J Haematol 2019;186:72-85. [PMID: 30919947 DOI: 10.1111/bjh.15884] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
8 Okamoto S. Current indication for hematopoietic cell transplantation in adults. Hematology/Oncology and Stem Cell Therapy 2017;10:178-83. [DOI: 10.1016/j.hemonc.2017.05.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
9 Infections after Hematopoietic Cell Transplantation: Progress? Hematopoietic Cell Transplants 2017. [DOI: 10.1017/9781316335727.017] [Reference Citation Analysis]
10 Tees MT, Riches ML. Infectious Diseases: Evaluation and Implications of Results in Hematopoietic Cell Transplants. Hematopoietic Cell Transplants 2017. [DOI: 10.1017/9781316335727.006] [Reference Citation Analysis]
11 Recipient Selection for Hematopoietic Cell Transplantation. Hematopoietic Cell Transplants 2017. [DOI: 10.1017/9781316335727.005] [Reference Citation Analysis]
12 Ljungman P. Prevention and Treatment of Viral Infections in Hematopoietic Cell Transplants. Hematopoietic Cell Transplants 2017. [DOI: 10.1017/9781316335727.018] [Reference Citation Analysis]
13 Larson AM, Mcdonald GB. Hepatobiliary Infections After Solid Organ or Hematopoietic Cell Transplantation. Transplant Infections 2016. [DOI: 10.1007/978-3-319-28797-3_36] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
14 Hockenbery DM, Strasser SI, Mcdonald GB. Gastrointestinal and Hepatic Complications. Thomas’ Hematopoietic Cell Transplantation 2016. [DOI: 10.1002/9781118416426.ch94] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
15 Young JH, Weisdorf DJ. Infections in Recipients of Hematopoietic Stem Cell Transplants. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 2015. [DOI: 10.1016/b978-1-4557-4801-3.00312-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Beckerich F, Hézode C, Robin C, Beaumont JL, Gautier E, Maury S, Cordonnier C. New nucleotide polymerase inhibitors to rapidly permit hematopoietic stem cell donation from a positive HCV-RNA donor. Blood 2014;124:2613-4. [PMID: 25323689 DOI: 10.1182/blood-2014-06-582122] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
17 Hsiao H, Liu Y, Wang H, Wu C, Cho S, Hsu J, Tsai H, Hsiao S, Chang C, Lin S, Liu T, Chuang W, Yu M. Hepatitis C transmission from viremic donors in hematopoietic stem cell transplant. Transpl Infect Dis 2014;16:1003-6. [DOI: 10.1111/tid.12306] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
18 Mikulska M, Nicolini L, Signori A, Rivoli G, Del Bono V, Raiola A, Di Grazia C, Dominietto A, Varaldo R, Ghiso A, Bacigalupo A, Viscoli C. Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome. Clinical Microbiology and Infection 2014;20:O694-701. [DOI: 10.1111/1469-0691.12611] [Cited by in Crossref: 60] [Cited by in F6Publishing: 66] [Article Influence: 7.5] [Reference Citation Analysis]
19 Norvell JP. Liver disease after hematopoietic cell transplantation in adults. Transplant Rev (Orlando) 2015;29:8-15. [PMID: 25315987 DOI: 10.1016/j.trre.2014.08.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
20 Frange P, Leruez-ville M, Neven B, Mascard L, Moshous D, Touzot F, Heritier S, Chaix M, Cavazzana M, Casanova J, Fischer A, Blanche S. Safety of hematopoietic stem cell transplantation from hepatitis B core antibodies-positive donors with low/undetectable viremia in HBV-naïve children. Eur J Clin Microbiol Infect Dis 2014;33:545-50. [DOI: 10.1007/s10096-013-1982-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]